Abbott Labs Glaukos: Which Stock Is Best to Buy in 2026
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
Daily volatility informs risk tolerance and timing decisions. This overview highlights why investors should monitor volatility and adjust strategies.
28,131 articlesIn 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
Zscaler posted a strong quarter, beating revenue and EPS estimates while signaling durable ARR growth. Here are the n...
Intel remains the Dow's most shorted stock as fresh data show rising short interest amid continued cash burn in the f...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
LoanDepot filed a $250 million shelf registration with the SEC to raise capital over time, signaling a liquidity-focu...
Three heavyweights are quietly reshaping how money moves across borders. Ripple, SWIFT and Visa are testing new rails...
In a market obsessed with the next AI breakthrough, one stock stands out not for hype but for real, lasting traction....
Macy's just strongest years momentum is starting to show in a stronger Q1. This article breaks down three practical t...
Citigroup boosts its SanDisk price target to $2,500, arguing a multi-year datacenter expansion and a tighter NAND cyc...
Bitcoin sits in a bitcoin deep value zone as on-chain signals show ongoing selling pressure from long-term holders. T...
Two refining giants posted solid Q4 results, signaling a strong 2026 for the sector. The question on investors’ minds...
Ripple is channeling billions into infrastructure to connect traditional finance with blockchain systems, reshaping t...